Finite versus indefinite nucleos(t)ide analogue therapy of patients with chronic hepatitis b exhibiting negative hbsag levels after treatment

HIGHLIGHTS

  • who: Haixia Sun and collaborators from the Department of Infectious Diseases, The Third Affiliated Hospital of Zhongshan University, No, Tianhe Road, Guangzhou, Guangdong, China have published the article: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment, in the Journal: BioMed Research International 80 of 14/07/2022
  • what: Thirtythree of these 104 patients were excluded for the following reasons: inadequate serum for analysis (n=16), liver cirrhosis (n=9), lost to follow-up (n=5), and hepatocellular carcinoma (n=3). The aim of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?